Previous close | 12.98 |
Open | 13.10 |
Bid | 0.00 x 3000 |
Ask | 0.00 x 2200 |
Day's range | 12.93 - 13.48 |
52-week range | 12.85 - 30.41 |
Volume | |
Avg. volume | 4,848,583 |
Market cap | 2.252B |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.34 |
Earnings date | 25 Apr 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 19.70 |
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
In the latest trading session, Teladoc (TDOC) closed at $13.14, marking a +0.08% move from the previous day.
PURCHASE, NY, April 15, 2024 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced today that the conference call to review its first quarter 2024 results, previously scheduled for 4:30 p.m. E.T. on April 25, 2024, will now start at 5:00 p.m. E.T. on that same day. Conference Call DetailsThe conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 901506. For international participants,